Patients Discontinuing Anti-Obesity Jabs Gain Back Weight Four Times Faster Than Those on Conventional Diets

Fresh analysis suggests that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt conventional diet and exercise regimens.

Research printed in a leading health publication shows that while overweight people can lose a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"Users buying such medications should be informed of the risk of rapid weight regain when the treatment is stopped," stated researcher Dr. Susan Jebb.

This pace of recovery implies a return to original weight within about 18 months.

Weighing Approaches

The study, which reviewed dozens of trials involving over 9,000 of patients, compared the outcomes of these new drugs with other pills.

Scientists point out that individuals who lose weight through lifestyle changes alone usually experience a less rapid weight regain—around 0.1 kg a month—after stopping.

Explaining the Fast Regain

Experts propose the mechanism of the drugs explains the heightened rebound.

The injections copy a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone concentrations several times higher than normal may cause the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is no longer kept in check, making overeating far more likely."

A Lifelong Condition?

The NHS advise the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Professionals say that, due to the likelihood of weight regain, the therapy might need to be long-term.

This perspective is reinforced by drug manufacturers, who note that the findings "emphasize the long-term nature of excess weight," comparing it to managing conditions like hypertension.

User Testimonies

People who have stopped the jabs explain a intense return of hunger.

"It felt as if a switch flipping and I was suddenly starving," said one woman.

The struggle is exacerbated if individuals have not adopted sustainable dietary or behavioural modifications during therapy.

Widespread Interest

Figures show that millions of adults in the UK have tried these injections in the last 12 months, with interest being substantial.

• Use is more common among women compared to men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion obtain the medications through private prescriptions rather than public health services.

Finally, researchers caution that while these medications are powerful agents for weight loss, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle management.